Index reshuffles have put Acadia Healthcare Company (ACHC) in focus, as the stock moves out of several Russell 1000 and midcap benchmarks and into the Russell 2000 and its value subset.

The index reshuffle comes during a sharp shift in momentum for Acadia Healthcare Company, with the share price delivering a 21.41% 1 month return and 115.12% year to date, but a 59.01% decline in 3 year total shareholder return. This highlights how recent strength contrasts with weaker longer term performance and may reflect changing views on both its growth prospects and risk profile.

If this kind of volatility has your attention, it can be useful to see what else is moving in related areas of the market, starting with 40 healthcare AI stocks.

Acadia Healthcare Company has a sizeable behavioral health footprint and its stock has just swung sharply higher. Yet index shifts and a history of weaker longer term returns raise a simple issue: does the current price fairly reflect what you are getting?

Most Popular Narrative: 157.5% Overvalued

According to the most followed narrative on Acadia Healthcare Company, a fair value of $11.94 sits well below the recent $30.74 close, which puts the current surge in a different light.

This is not a high-growth technology story. It is a capacity-and-execution story in a market where demand is persistent and under-supplied. If Acadia continues to expand responsibly while maintaining care quality, its relevance is likely to increase rather than fade.

The fair value hinges on how quickly Acadia Healthcare Company can turn its behavioral health footprint into consistent profits, while keeping margins resilient and capital needs in check. The entire thesis rests on a specific blend of revenue growth, future profitability and the rate used to discount those cash flows. The detail behind those moving parts is what really matters here.

Result: Fair Value of $11.94 (OVERVALUED)

However, Acadia Healthcare Company still faces real pressure points, including the recent net loss of US$1,107.04m and a 59.01% decline in 3 year total shareholder return.

Another View on Acadia Healthcare Company’s Valuation

While the most popular narrative pins Acadia Healthcare Company at 157.5% above a $11.94 fair value, the SWS DCF model currently points the other way. It suggests the stock at $30.74 is trading at a very large discount to an estimated future cash flow value of $97.93. When one framework signals heavy downside risk and another implies a wide margin of safety, which story do you trust more for your own process?

Next Steps

If this mix of strong recent returns, longer term weakness and conflicting valuation views on Acadia Healthcare Company feels hard to balance, take a closer look at the numbers yourself and decide where you stand before sentiment shifts again by reviewing the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Acadia Healthcare Company?

If Acadia Healthcare Company has sparked your interest, do not stop there; broaden your watchlist with focused stock ideas built from clear financial filters and robust fundamentals.

• Target dependable cash generators by scanning 44 high quality undervalued stocks that combine quality fundamentals with prices that may sit below their estimated worth.
• Strengthen your income stream by reviewing 9 dividend fortresses that aim to pair higher yields with resilience.
• Prioritize resilience and sleep-better-at-night holdings by checking 72 resilient stocks with low risk scores that score well on financial stability and risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.